Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1990 1
1993 1
1994 1
1995 1
1996 1
1999 1
2001 1
2002 5
2003 1
2004 1
2008 1
2010 2
2011 7
2012 4
2013 6
2014 8
2015 7
2016 6
2017 6
2018 8
2019 9
2020 12
2021 17
2022 6
2023 9
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

112 results

Results by year

Filters applied: . Clear all
Page 1
The EMA Assessment of Asciminib for the Treatment of Adult Patients With Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase Who Were Previously Treated With at Least Two Tyrosine Kinase Inhibitors.
Tesileanu CMS, Michaleas S, Gonzalo Ruiz R, Mariz S, Fabriek BO, van Hennik PB, Dedorath J, Dekic B, Unkrig C, Brandt A, Koenig J, Enzmann H, Delgado J, Pignatti F. Tesileanu CMS, et al. Among authors: pignatti f. Oncologist. 2023 Jul 5;28(7):628-632. doi: 10.1093/oncolo/oyad119. Oncologist. 2023. PMID: 37141403 Free PMC article. Clinical Trial.
The value of anticancer drugs - a regulatory view.
Pignatti F, Wilking U, Postmus D, Wilking N, Delgado J, Bergh J. Pignatti F, et al. Nat Rev Clin Oncol. 2022 Mar;19(3):207-215. doi: 10.1038/s41571-021-00584-z. Epub 2021 Dec 6. Nat Rev Clin Oncol. 2022. PMID: 34873312 Review.
A Review of Causal Inference for External Comparator Arm Studies.
Rippin G, Ballarini N, Sanz H, Largent J, Quinten C, Pignatti F. Rippin G, et al. Among authors: pignatti f. Drug Saf. 2022 Aug;45(8):815-837. doi: 10.1007/s40264-022-01206-y. Epub 2022 Jul 27. Drug Saf. 2022. PMID: 35895225 Review.
Ethical Aspects of Regulating Oncology Products.
Guizzaro L, Drosos S, Kihlbom U, Pignatti F. Guizzaro L, et al. Among authors: pignatti f. Recent Results Cancer Res. 2021;218:119-134. doi: 10.1007/978-3-030-63749-1_9. Recent Results Cancer Res. 2021. PMID: 34019166
Early market access of cancer drugs in the EU.
Martinalbo J, Bowen D, Camarero J, Chapelin M, Démolis P, Foggi P, Jonsson B, Llinares J, Moreau A, O'Connor D, Oliveira J, Vamvakas S, Pignatti F. Martinalbo J, et al. Among authors: pignatti f. Ann Oncol. 2016 Jan;27(1):96-105. doi: 10.1093/annonc/mdv506. Epub 2015 Oct 20. Ann Oncol. 2016. PMID: 26487583 Free article. Review.
Randomized Controlled Trials Versus Real World Evidence: Neither Magic Nor Myth.
Eichler HG, Pignatti F, Schwarzer-Daum B, Hidalgo-Simon A, Eichler I, Arlett P, Humphreys A, Vamvakas S, Brun N, Rasi G. Eichler HG, et al. Among authors: pignatti f. Clin Pharmacol Ther. 2021 May;109(5):1212-1218. doi: 10.1002/cpt.2083. Epub 2020 Nov 12. Clin Pharmacol Ther. 2021. PMID: 33063841 Free PMC article. Review.
Current Status and Future Perspectives on Neoadjuvant Therapy in Lung Cancer.
Blumenthal GM, Bunn PA Jr, Chaft JE, McCoach CE, Perez EA, Scagliotti GV, Carbone DP, Aerts HJWL, Aisner DL, Bergh J, Berry DA, Jarkowski A, Botwood N, Cross DAE, Diehn M, Drezner NL, Doebele RC, Blakely CM, Eberhardt WEE, Felip E, Gianni L, Keller SP, Leavey PJ, Malik S, Pignatti F, Prowell TM, Redman MW, Rizvi NA, Rosell R, Rusch V, de Ruysscher D, Schwartz LH, Sridhara R, Stahel RA, Swisher S, Taube JM, Travis WD, Keegan P, Wiens JR, Wistuba II, Wynes MW, Hirsch FR, Kris MG. Blumenthal GM, et al. Among authors: pignatti f. J Thorac Oncol. 2018 Dec;13(12):1818-1831. doi: 10.1016/j.jtho.2018.09.017. Epub 2018 Sep 27. J Thorac Oncol. 2018. PMID: 30268698 Free article. Review.
Quantifying Preferences in Drug Benefit-Risk Decisions.
Tervonen T, Angelis A, Hockley K, Pignatti F, Phillips LD. Tervonen T, et al. Among authors: pignatti f. Clin Pharmacol Ther. 2019 Nov;106(5):955-959. doi: 10.1002/cpt.1447. Epub 2019 Apr 24. Clin Pharmacol Ther. 2019. PMID: 30929257
Off-label despite high-level evidence: a clinical practice review of commonly used off-patent cancer medicines.
Zarkavelis G, Amylidi AL, Verbaanderd C, Cherny NI, Metaxas Y, de Vries EGE, Zygoura P, Amaral T, Jordan K, Strijbos M, Dafni U, Latino N, Galotti M, Lordick F, Giuliani R, Pignatti F, Pentheroudakis G. Zarkavelis G, et al. Among authors: pignatti f. ESMO Open. 2023 Feb;8(1):100604. doi: 10.1016/j.esmoop.2022.100604. Epub 2022 Nov 14. ESMO Open. 2023. PMID: 36870739 Free PMC article. Review.
112 results